These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 34152967)
21. The use of laboratory-identified event surveillance to classify adverse outcomes due to Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722 [TBL] [Abstract][Full Text] [Related]
22. Investigating the association of room features with healthcare-facility-onset Root ED; Lindstrom M; Xie A; Mangino JE; Moffatt-Bruce S; Hebert C Infect Control Hosp Epidemiol; 2021 Jul; 42(7):847-852. PubMed ID: 33261688 [TBL] [Abstract][Full Text] [Related]
23. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence. McFarland LV; Johnson SB; Evans CT Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261 [TBL] [Abstract][Full Text] [Related]
24. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients. Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250 [TBL] [Abstract][Full Text] [Related]
33. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center. Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067 [TBL] [Abstract][Full Text] [Related]
34. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals. Legenza L; Coetzee R; Rose WE; Esack T; Crombie K; Mina M; Safdar N; Barnett SG Res Social Adm Pharm; 2022 Dec; 18(12):4100-4111. PubMed ID: 35981939 [TBL] [Abstract][Full Text] [Related]
35. [Interpretation of group standard for Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698 [TBL] [Abstract][Full Text] [Related]
36. The Impact of Clinical Decision Support Alerts on Clostridioides difficile Testing: A Systematic Review. Dunn AN; Radakovich N; Ancker JS; Donskey CJ; Deshpande A Clin Infect Dis; 2021 Mar; 72(6):987-994. PubMed ID: 32060501 [TBL] [Abstract][Full Text] [Related]
37. What is the current state of patient education after DeBenedictus CM; Hecker MT; Zuccaro PD; John JP; Donskey CJ; Patel PK Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1338-1340. PubMed ID: 32772981 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of Clostridioides difficile infection. Mateu L; Fernández-Rivas G; Sopena N Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207 [TBL] [Abstract][Full Text] [Related]
39. Clostridioides difficile infections among healthcare workers. Aguirre-García GM; Garza-González E; Morfin-Otero R; Camacho-Ortiz A Am J Infect Control; 2020 Oct; 48(10):1270-1272. PubMed ID: 32122672 [TBL] [Abstract][Full Text] [Related]
40. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia. Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]